Showing results (1551-1560 of 5,920) with videos related to

Sort By:
Pageof 592
Arthritis Research & Therapy|January 27, 2018
Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupusSamantha A Chalmers, Jing Wen, Jessica Doerner, et al.
Arthritis Research & Therapy|March 1, 2018
Longitudinal stability of fibromyalgia symptom clustersTanya L Hoskin, Mary O Whipple, Sanjeev Nanda, et al.
Arthritis Research & Therapy|February 1, 2018
Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR groupSabine Adler, Dörte Huscher, Elise Siegert, et al.
Arthritis Research & Therapy|March 9, 2018
Sirukumab in rheumatoid arthritis refractory to sulfasalazine or methotrexate: a randomized phase 3 safety and efficacy study in Japanese patientsTsutomu Takeuchi, Hisashi Yamanaka, Masayoshi Harigai, et al.
Arthritis Research & Therapy|February 16, 2018
Correction to: Patients and surgeons provide endorsement of core domains for total joint replacement clinical trialsAnh Hoang, Susan M Goodman, Iris Y Navarro-Millán, et al.
Arthritis Research & Therapy|February 14, 2018
Identification of a novel autoantibody against self-vimentin specific in secondary Sjögren's syndromeYu-Hui Li, Ya-Ping Gao, Jie Dong, et al.
Arthritis Research & Therapy|February 14, 2018
Thinking BIG rheumatology: how to make functional genomics data work for youDeborah R Winter
Arthritis Research & Therapy|December 2, 2017
New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 casesKazunori Yamada, Motohisa Yamamoto, Takako Saeki, et al.
Arthritis Research & Therapy|December 2, 2017
The role of aberrant expression of T cell miRNAs affected by TNF-α in the immunopathogenesis of rheumatoid arthritisNing-Sheng Lai, Hui-Chun Yu, Chien-Hsueh Tung, et al.
Arthritis Research & Therapy|November 12, 2017
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosusMatteo Piga, Alberto Floris, Giulia Cappellazzo, et al.
Pageof 592